Fourth Universal Definition of Myocardial Infarction (2018)

Journal of the American College of Cardiology

Volumn 72, Issue 18, 2018, Pages 2231-2264

  Thygesen, Kristian ^a   Alpert, Joseph S ^a,b   Jaffe, Allan S ^a   Chaitman, Bernard R ^a   Bax, Jeroen J ^a   Morrow, David A ^a   White, Harvey D ^a,c  

^a University of Arizona College of Medicine ^*

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

cardiac procedural myocardial injury; cardiac troponin; Expert Consensus Document; high sensitivity cardiac troponin; myocardial infarction; myocardial infarction with non obstructive coronary arteries (MINOCA); myocardial injury; prior myocardial infarction; re infarction; recurrent myocardial infarction; silent myocardial infarction; Takotsubo syndrome; type 1 MI; type 2 MI; type 3 MI; type 4a MI; type 4b MI; type 4c MI; type 5 MI

Indexed keywords

TROPONIN I; TROPONIN T; BIOLOGICAL MARKER;

ARTICLE; ASSAY; ATRIAL FIBRILLATION; CARDIAC TROPONIN ASSAY; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEALTH CARE SYSTEM; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; MEDICAL PROCEDURES; MYOCARDIAL INFARCTION WITH NON OBSTRUCTIVE CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; SCINTISCANNING; ST SEGMENT ELEVATION; STENT THROMBOSIS; TAKOTSUBO CARDIOMYOPATHY; TRANSCATHETER VALVE INTERVENTION; TYPE 1 MYOCARDIAL INFARCTION; TYPE 2 MYOCARDIAL INFARCTION; TYPE 3 MYOCARDIAL INFARCTION; TYPE 4 MYOCARDIAL INFARCTION; TYPE 5 MYOCARDIAL INFARCTION; ADVERSE EVENT; BLOOD; CARDIOLOGY; DIAGNOSTIC IMAGING;

BIOMARKERS; CARDIOLOGY; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION;

EID: 85055313682     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.08.1038     Document Type: Article

References (201)

1. Hammer, A., Ein Fall von thrombotischem Verschlusse einer der Kranzarterien des Herzens. Wien Med Wschr 28 (1878), 97–102.
2. Obraztzow, V.P., Straschesko, N.D., Zur Kenntnis der Thrombose der Koronararterien des Herzens. Z Klin Med 71 (1910), 116–132.
3. Herrick, J.B., Clinical features of sudden obstruction of the coronary arteries. JAMA 59 (1912), 2015–2022.
4. Friedberg, C.K., Horn, H., Acute myocardial infarction not due to coronary artery occlusion. JAMA 112 (1939), 1675–1679.
5. World Health Organization. Working Group on the Establishment of Ischemic Heart Disease Registers. Report of the Fifth Working Group, Copenhagen. Report No. Eur 8201 (5), 1971, World Health Organization, Geneva.
6. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59 (1979), 607–609.
7. Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.M., Pajak, A., Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994), 583–612.
8. Luepker, R.V., Apple, F.S., Christenson, R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003), 2543–2549.
9. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000), 1502–1513 J Am Coll Cardiol 2000;36:959–69.
10. Thygesen, K., Alpert, J.S., White, H.D., Joint ESC/ACC/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007), 2525–2538 Circulation 2007;116:2634–53; J Am Coll Cardiol 2007;50:2173–95.
11. Mendis, S., Thygesen, K., Kuulasmaa, K., et al., Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 40 (2011), 139–146.
12. Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., Writing Group on the Joint ESC/ACC/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 33 (2012), 2551–2567 Circulation 2012;126:2020–2035; J Am Coll Cardiol 2012;60:1581–98.
13. Sarkisian, L., Saaby, L., Poulsen, T.S., et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med, 129, 2016 446e.5–446e.21.
14. Sarkisian, L., Saaby, L., Poulsen, T.S., et al. Prognostic impact of myocardial injury related to various cardiac and noncardiac conditions. Am J Med 129 (2016), 506–514.
15. Ooi, D.S., Isotalo, P.A., Veinot, J.P., Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 46 (2000), 338–344.
16. Jennings, R.B., Ganote, C.E., Structural changes in myocardium during acute ischemia. Circ Res 35 (1974), 156–172.
17. Virmani, R., Forman, M.B., Kolodgie, F.D., Myocardial reperfusion injury. Histopathological effects of perfluorochemical. Circulation 81 (1990), IV57–IV68.
18. Reimer, K.A., Jennings, R.B., Tatum, A.H., Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies. Am J Cardiol 52 (1983), 72A–81A.
19. Ibáñez, B., Heusch, G., Ovize, M., Van de Werf, F., Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 65 (2015), 1454–1471.
20. Montecucco, F., Carbone, F., Schindler, T.H., Pathophysiology of ST-segment elevation myocardial infarction: Novel mechanisms and treatments. Eur Heart J 37 (2016), 1268–1283.
21. Thygesen, K., Mair, J., Katus, H., et al., The Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 31 (2010), 2197–2204.
22. Thygesen, K., Mair, J., Giannitsis, E., et al., Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 33 (2012), 2252–2257.
23. Rittoo, D., Jones, A., Lecky, B., Neithercut, D., Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: Implications for the diagnosis of myocardial infarction. J Am Coll Cardiol 63 (2014), 2411–2420.
24. Jaffe, A.S., Vasile, V.C., Milone, M., Saenger, A.K., Olson, K.N., Apple, F.S., Diseased skeletal muscle: A noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 58 (2011), 1819–1824.
25. Wens, S.C.A., Schaaf, G.J., Michels, M., et al. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease. Circ Cardiovasc Genet 9 (2016), 6–13.
26. Mair, J., Lindahl, B., Müller, C., et al. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care 7 (2018), 577–586.
27. Mair, J., Lindahl, B., Hammarsten, O., et al. European Society of Cardiology (ESC) Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association (ACCA). How is cardiac troponin released from injured myocardium?. Eur Heart J Acute Cardiovasc Care. 7 (2018), 553–560.
28. Vestergaard, K.R., Jespersen, C.B., Arnadottir, A., et al. Prevalence and significance of troponin elevations in patients without acute coronary disease. Int J Cardiol 222 (2016), 819–825.
29. Schmid, J., Liesinger, L., Birner-Gruenberger, R., et al. Elevated cardiac troponin T in skeletal myopathies. J Am Cardiol Coll 71 (2018), 1540–1549.
30. Apple, F.S., Jaffe, A.S., Collinson, P., et al., on behalf of the International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 48 (2015), 201–203.
31. Goodman, S.G., Steg, P.G., Eagle, K.A., et al., GRACE Investigators. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: Lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 151 (2006), 654–660.
32. Weil, B.R., Suzuki, G., Young, R.F., Iyer, V., Canty, J.M. Jr., Troponin release and reversible left ventricular dysfunction following transient pressure overload: Stress-induced myocardial stunning. J Am Cardiol Coll 71 (2018), 2906–2916.
33. Turer, A.T., Addo, T.A., Martin, J.L., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: Insights from a coronary sinus sampling study. J Am Coll Cardiol 57 (2011), 2398–2405.
34. Siriwardena, M., Campbell, V., Richards, A.M., Pemberton, C.J., Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. Clin Chem 58 (2012), 1492–1494.
35. White, H.D., Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as necrosis?. J Am Coll Cardiol 57 (2011), 2406–2408.
36. Jaffe, A.S., Wu, A.H., Troponin release—reversible or irreversible injury? Should we care?. Clin Chem 58 (2012), 148–150.
37. Eggers, K.M., Lindahl, B., Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 63 (2017), 223–235.
38. Giannitsis, E., Katus, H.A., Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol 10 (2013), 623–634.
39. Agewall, S., Giannitsis, E., Jernberg, T., Katus, H., Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 32 (2011), 404–411.
40. Kelley, W.E., Januzzi, J.L., Christenson, R.H., Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 55 (2009), 2098–2112.
41. Jeremias, A., Gibson, C.M., Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142 (2005), 786–791.
42. Weil, B.R., Young, R.F., Shen, X., et al. Brief myocardial ischemia produces cardiac troponin I release and focal myocyte apoptosis in the absence of pathological infarction in swine. JACC Basic Transl Sci 2 (2017), 105–114.
43. Braunwald, E., Morrow, D.A., Unstable angina: Is it time for a requiem?. Circulation 127 (2013), 2452–2457.
44. Bentzon, J.F., Otsuka, F., Virmani, R., Falk, E., Mechanisms of plaque formation and rupture. Circ Res 114 (2014), 1852–1866.
45. Falk, E., Nakano, M., Bentzon, J.F., Finn, A.V., Virmani, R., Update on acute coronary syndromes: The pathologists’ view. Eur Heart J 34 (2013), 719–728.
46. Ibanez, B., James, S., Agewall, S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39 (2018), 119–177.
47. Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST- segment elevation. Eur Heart J 37 (2016), 267–315.
48. Saaby, L., Poulsen, T.S., Hosbond, S., et al. Classification of myocardial infarction: Frequency and features of type 2 myocardial infarction. Am J Med 126 (2013), 789–797.
49. Cediel, G., Gonzalez-del-Hoyo, M., Carrasquer, A., Sanchez, R., Boqué C., Bardaji, A., Outcomes with type 2 myocardial infarction compared with non-ischemic myocardial injury. Heart 103 (2017), 616–622.
50. Baron, T., Hambraeus, K., Sundström, J., Erlinge, D., Jernberg, T., Lindahl, B., TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart 101 (2015), 101–106.
51. Shah, A.S., McAllister, D.A., Mills, R., et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 128 (2015), 493–501.
52. Gupta, S., Vaidya, S.R., Arora, S., Bahekar, A., Devarapally, S.R., Type 2 versus type 1 myocardial infarction: A comparison of clinical characteristics and outcomes with a meta- analysis of observational studies. Cardiovasc Diagn Ther 7 (2017), 348–358.
53. Sandoval, Y., Thygesen, K., Myocardial infarction type 2 and myocardial injury. Clin Chem 63 (2017), 101–107.
54. Saaby, L., Poulsen, T.S., Diederichsen, A.C.P., et al. Mortality rate in type 2 myocardial infarction: Observations from an unselected hospital cohort. Am J Med 127 (2014), 295–302.
55. Lambrecht, S., Sarkisian, L., Saaby, L., et al. Different causes of death in patients with myocardial infarction type 1, type 2 and myocardial injury. Am J Med 131 (2018), 548–554.
56. Chapman, A.R., Shah, A.S.V., Lee, K.K., et al. Long term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 137 (2018), 1236–1245.
57. Neumann, J.T., Sörensen, N.A., Rübsamen, N., et al. Discrimination of patients with type 2 myocardial infarction. Eur Heart J 38 (2017), 3514–3520.
58. Saw, J., Mancini, G.B., Humphries, K.H., Contemporary review on spontaneous coronary artery dissection. J Am Coll Cardiol 68 (2016), 297–312.
59. Januzzi, J.L., Sandoval, Y., The many faces of type 2 myocardial infarction. J Am Coll Cardiol 70 (2017), 1569–1572.
60. Jangaard, N., Sarkisian, L., Saaby, L., et al. Incidence, frequency and clinical characteristics of type 3 myocardial infarction in clinical practice. Am J Med 130 (2017), 862.e9–862.e14.
61. Selvanayagam, J.B., Petersen, S.E., Francis, J.M., et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 109 (2004), 345–350.
62. Selvanayagam, J.B., Porto, I., Channon, K., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 111 (2005), 1027–1032.
63. Rahimi, K., Banning, A.P., Cheng, A.S., et al. Prognostic value of coronary revascularisation- related myocardial injury: A cardiac magnetic resonance imaging study. Heart 95 (2009), 1937–1943.
64. Tricoci, P., Consensus or controversy?: Evolution of criteria for myocardial infarction after percutaneous coronary intervention. Clin Chem 63 (2017), 82–90.
65. Ndrepepa, G., Colleran, R., Braun, S., et al. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol 68 (2016), 2259–2268.
66. Zeitouni, M., Silvain, J., Guedeney, P., et al., ACTION Study Group. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J 39 (2018), 1100–1109.
67. Thygesen, K., Jaffe, A.S., The prognostic impact of periprocedural myocardial infarction and injury. Eur Heart J 39 (2018), 1110–1112.
68. Garcia-Garcia, H.M., McFadden, E.P., Farb, A., et al. Standardized endpoint definitions for coronary intervention trials: The Academic Research Consortium-2 Consensus Document. Eur Heart J 39 (2018), 2192–2207 Circulation 2018;137:2635–50.
69. Pegg, T.J., Maunsell, Z., Karamitsos, T.D., et al. Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: Insights from serial cardiac MRI. Heart 97 (2011), 810–816.
70. Jørgensen, P.H., Nybo, M., Jensen, M.K., et al. Optimal cut-off value for cardiac troponin I in ruling out type 5 myocardial infarction. Interact Cardiovasc Thorac Surg 18 (2014), 544–550.
71. Wang, T.K., Stewart, R.A., Ramanathan, T., Kang, N., Gamble, G., White, H.D., Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: Relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care 2 (2013), 323–333.
72. Thielmann, M., Sharma, V., Al-Attar, N., et al. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery. Eur Heart J 38 (2017), 2392–2411.
73. Moussa, I.D., Klein, L.W., Shah, B., et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol 62 (2013), 1563–1570.
74. Apple, F.S., Murakami, M.M., Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem 51 (2005), 460–463.
75. Sinning, J.M., Hammerstingl, C., Schueler, R., et al. The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. EuroIntervention 11 (2016), 1522–1529.
76. Wang, T.K.M., Stewart, R.A.H., Ramanathan, T., Choi, D., Gamble, G., Ruygrok, P.N., White, H.D., Diagnosis of myocardial infarction and prognostic utility of high-sensitivity troponin T after isolated aortic valve replacement. Clin Trials Regul Sci Cardiol 16 (2016), 1–5.
77. Devereaux, P.J., Xavier, D., Pogue, J., et al., POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: A cohort study. Ann Intern Med 154 (2011), 523–528.
78. The Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307 (2012), 2295–2304.
79. Nagele, P., Brown, F., Gage, B.F., et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J 166 (2013), 325–332.
80. Weber, M., Luchner, A., Manfred, S., et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for perioperative risk stratification in non-cardiac surgery. Eur Heart J 34 (2013), 853–862.
81. Kavsak, P.A., Walsh, M., Srinathan, S., et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: A prospective cohort study. Clin Biochem 44 (2011), 1021–1024.
82. Devereaux, P.J., Biccard, B.M., Sigamani, A., et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA 317 (2017), 1642–1651.
83. Puelacher, C., Lurati Buse, G., Seeberger, D., et al. Perioperative myocardial injury after noncardiac surgery: Incidence, mortality, and characterization. Circulation 137 (2018), 1221–1232.
84. Duvall, W.L., Sealove, B., Pungoti, C., Katz, D., Moreno, P., Kim, M., Angiographic investigation of the pathophysiology of perioperative myocardial infarction. Catheter Cardiovasc Interv 80 (2012), 768–776.
85. Landesberg, G., Beattie, W.S., Mosseri, M., Jaffe, A.S., Alpert, J.S., Perioperative myocardial infarction. Circulation 119 (2009), 2936–2944.
86. Hanson, I., Kahn, J., Dixon, S., Goldstein, J., Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheter Cardiovasc Interv 82 (2013), 622–628.
87. Gualandro, D.M., Campos, C.A., Calderaro, D., et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: Frequent and dangerous. Atherosclerosis 222 (2012), 191–195.
88. Kociol, R.D., Pang, P.S., Gheorghiade, M., Fonarow, G.C., O'Connor, C.M., Felker, G.M., Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 56 (2010), 1071–1078.
89. Januzzi, J.L. Jr., Filippatos, G., Nieminen, M., Gheorghiade, M., Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J 33 (2012), 2265–2271.
90. Lyon, A.R., Bossone, E., Schneider, B., et al. Current state of knowledge on Takotsubo syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 18 (2016), 8–27.
91. Templin, C., Ghadri, J.R., Diekmann, J., et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 373 (2015), 929–938.
92. Medeiros, K., O'Connor, M.J., Baicu, C.F., et al. Systolic and diastolic mechanics in stress cardiomyopathy. Circulation 129 (2014), 1659–1667.
93. Sharkey, S.W., Lesser, J.R., Zenovich, A.G., et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 111 (2005), 472–479.
94. Redfors, B., Råmunddal, T., Shao, Y., Omerovic, E., Takotsubo triggered by acute myocardial infarction: A common but overlooked syndrome?. J Geriatr Cardiol 11 (2014), 171–173.
95. Agewall, S., Beltrame, J.F., Reynolds, H.R., et al., Working Group on Cardiovascular Pharmacotherapy. ESC Working Group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 38 (2017), 143–153.
96. Lindahl, B., Baron, T., Erlinge, D., et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation 135 (2017), 1481–1489.
97. Pasupathy, S., Air, T., Dreyer, R.P., Tavella, R., Beltrame, J.F., Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131 (2015), 861–870.
98. Smilowitz, N.R., Mahajan, A.M., Roe, M.T., et al. Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). Circ Cardiovasc Qual Outcomes, 10, 2017, e003443.
99. Jacobs, L.H., van de Kerkhof, J., Mingels, A.M., et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 46 (2009), 283–290.
100. Unger, E.D., Dubin, R.F., Deo, R., et al. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 18 (2016), 103–112.
101. Twerenbold, R., Wildi, K., Jaeger, C., et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 131 (2015), 2041–2050.
102. deFilippi, C., Seliger, S.L., Kelley, W., et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem 58 (2012), 1342–1351.
103. Michos, E.D., Wilson, L.M., Yeh, H.C., et al. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: A systematic review and meta-analysis. Ann Intern Med 161 (2014), 491–501.
104. Parikh, R.H., Seliger, S.L., deFilippi, C.R., Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem 48 (2015), 247–253.
105. Friden, V., Starnberg, K., Muslimovic, A., et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem 50 (2017), 468–474.
106. Stacy, S.R., Suarez-Cuervo, C., Berger, Z., et al. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: A systematic review. Ann Intern Med 161 (2014), 502–512.
107. Guest, T.M., Ramanathan, A.V., Tuteur, P.G., Schechtman, K.B., Ladenson, J.H., Jaffe, A.S., Myocardial injury in critically ill medical patients: A surprisingly frequent complication. JAMA 273 (1995), 1945–1949.
108. Babuin, L., Vasile, V.C., Rio Perez, J.A., et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 36 (2008), 759–765.
109. Landesberg, G., Vesselov, Y., Einav, S., Goodman, S., Sprung, C.L., Weissman, C., Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med 33 (2005), 1281–1287.
110. Thygesen, K., Alpert, J.S., Jaffe, A.S., White, H.D., Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr Opin Crit Care 14 (2008), 543–548.
111. Vatner, S.F., Baig, H., Manders, W.T., Maroko, P.R., The effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 61 (1978), 1048–1056.
112. Starnberg, K., Jeppsson, A., Lindahl, B., Hammarsten, O., Revision of the troponin T release mechanism from damaged human myocardium. Clin Chem 60 (2014), 1098–1104.
113. Jaffe, A.S., Moeckel, M., Giannitsis, E., Huber, K., et al. In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: A position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care 3 (2014), 313–316.
114. Reichlin, T., Irfan, A., Twerenbold, R., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124 (2011), 136–145.
115. Mueller, M., Biener, M., Vafaie, M., et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 58 (2012), 209–218.
116. Keller, T., Zeller, T., Ojeda, F., et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 306 (2011), 2684–2693.
117. Jaffe, A.S., Apple, F.S., Morrow, D.A., Lindahl, B., Katus, H.A., Being rational about (im)precision: A statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task force for the definition of myocardial infarction. Clin Chem 56 (2010), 941–943.
118. th percentile value of cardiac troponin. Clin Chem 60 (2013), 455–462.
119. Apple, F.S., Sandoval, Y., Jaffe, A.S., Ordonez-Llanos, J., IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: Guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 63 (2017), 73–81.
120. Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A.S., Katus, H.A., Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56 (2010), 254–261.
121. Frankenstein, L., Wu, A.H.B., Hallermayer, K., Wians, F.H., Giannitsis, E., Katus, H.A., Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 57 (2011), 1068–1071.
122. Apple, F.S., Ler, R., Murakami, M.M., Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58 (2012), 1574–1581.
123. Wu, A.H.B., Christenson, R.H., Greene, D.N., et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: Expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio- Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem 64 (2018), 645–655.
124. Collinson, P.O., Heung, Y.M., Gaze, D., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 58 (2012), 219–225.
125. McKie, P.M., Heublein, D.M., Scott, C.G., et al. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem 59 (2013), 1099–1107.
126. Olivieri, F., Galeazzi, R., Giavarina, D., et al. Aged-related increase of high sensitive troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech Ageing Dev 133 (2012), 300–305.
127. Reiter, M., Twerenbold, R., Reichlin, T., et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 32 (2011), 1379–1389.
128. Shah, A.S., Griffiths, M., Lee, K.K., et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: Prospective cohort study. BMJ, 350, 2015, g7873.
129. Eggers, K.M., Johnston, N., James, S., Lindahl, B., Venge, P., Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender. Am Heart J, 168, 2014 317.e1–324.e1.
130. Balmelli, C., Meune, C., Twerenbold, R., et al. Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. Am Heart J 166 (2013), 30–37.
131. Bjurman, C., Larsson, M., Johanson, P., et al. Small changes in troponin T levels are common in patients with non-ST segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 62 (2013), 1231–1238.
132. D'Souza, M., Sarkisian, L., Saaby, L., et al. Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays. Am J Med 128 (2015), 852–860.
133. Reichlin, T., Twerenbold, R., Reiter, M., et al. Introduction of high-sensitivity troponin assays: Impact on myocardial infarction incidence and prognosis. Am J Med 125 (2012), 1205–1213.
134. Sandoval, Y., Apple, F.S., Smith, S.W., High-sensitivity cardiac troponin assays and unstable angina. Eur Heart J Acute Cardiovasc Care 7 (2018), 120–128.
135. Morrow, D.A., Clinician's guide to early rule-out strategies with high-sensitivity cardiac troponin. Circulation 135 (2017), 1612–1616.
136. Twerenbold, R., Boeddinghaus, J., Nestelberger, T., et al. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 70 (2017), 996–1012.
137. Cullen, L., Mueller, C., Parsonage, W.A., et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 62 (2013), 1242–1249.
138. Pickering, J.W., Than, M.P., Cullen, L., et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: A collaborative meta-analysis. Ann Intern Med 166 (2017), 715–724.
139. Mueller, C., Giannitsis, E., Möckel, M., et al., Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: Novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care 6 (2017), 218–222.
140. Boeddinghaus, J., Nestelberger, T., Twerenbold, R., et al. Direct comparison of 4 very early rule- out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I. Circulation 135 (2017), 1597–1611.
141. Möckel, M., Giannitsis, E., Mueller, C., et al. Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care 6 (2017), 212–217.
142. Jaffe, A.S., White, H., Ruling-in myocardial injury and ruling-out myocardial infarction with the European Society of Cardiology (ESC) 1-hour algorithm. Circulation 134 (2016), 1542–1545.
143. Sandoval, Y., Herzog, C.A., Love, S.A., et al. Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients. Clin Chem 62 (2016), 631–638.
144. DeFilippi, C.F., Herzog, C.A., Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem 63 (2017), 59–65.
145. Neeland, I.J., Drazner, M.H., Berry, J.D., et al. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol 61 (2013), 187–195.
146. Biner, M., Mueller, M., Vafaie, M., et al. Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population. Eur Heart J Acute Cardiovasc Care 2 (2013), 314–322.
147. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 64 (2014), e139–e228.
148. Bagai, A., Jollis, J.G., Dauerman, H.L., et al. Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram. Circulation 128 (2013), 352–359.
149. Scirica, B.M., Morrow, D.A., Budaj, A., et al. Ischemia detected on continuous electrocardiography after acute coronary syndrome. J Am Coll Cardiol 53 (2009), 1411–1421.
150. Wang, K., Asinger, R.W., Marriott, H.J., ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349 (2003), 2128–2135.
151. de Winter, R.J., Verouden, N.J.W., Wellens, H.J.J., Wilde, A.A.M., A new ECG sign of proximal LAD occlusion. N Engl J Med 359 (2008), 2071–2073.
152. de Winter, R.W., Adams, R., Verouden, N.J.W., de Winter, R.J., Precordial junctional ST-segment depression with tall symmetric T-waves signifying proximal LAD occlusion, case reports of STEMI equivalence. J Electrocardiol 49 (2016), 76–80.
153. de Zwaan, C., Bär, F.W.H.M., Wellens, H.J.J., Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J 103 (1982), 730–736.
154. Wong, C.K., Gao, W., Stewart, R.A., et al., HERO-2 Investigators. aVR ST elevation: An important but neglected sign in ST elevation acute myocardial infarction. Eur Heart J 31 (2010), 1845–1853.
155. 7–9: “Hidden” ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol 34 (1999), 748–753.
156. Wong, C.K., White, H.D., Patients with circumflex occlusions miss out on reperfusion: How to recognize and manage them. Curr Opin Cardiol 27 (2012), 327–330.
157. 3. J Am Coll Cardiol 6 (1985), 1273–1279.
158. Deluigi, C.C., Ong, P., Hill, S., et al. ECG findings in comparison to cardiovascular MR imaging in viral myocarditis. Int J Cardiol 165 (2013), 100–106.
159. Biagini, E., Pazzi, C., Olivotto, I., et al. Usefulness of electrocardiographic patterns at presentation to predict long-term risk of cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 118 (2016), 432–439.
160. Guerra, F., Rrapaj, E., Pongetti, G., et al. Differences and similarities of repolarization patterns during hospitalization for takotsubo cardiomyopathy and acute coronary syndrome. Am J Cardiol 112 (2013), 1720–1724.
161. Savage, R.M., Wagner, G.S., Ideker, R.E., Podolsky, S.A., Hackel, D.B., Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: Retrospective study of patients with typical anterior and posterior infarcts. Circulation 55 (1977), 279–285.
162. Horan, L.G., Flowers, N.C., Johnson, J.C., Significance of the diagnostic Q wave of myocardial infarction. Circulation 43 (1971), 428–436.
163. Chaitman, B.R., Hardison, R.M., Adler, D., et al., Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease. Circulation 120 (2009), 2529–2540.
164. Burgess, D.C., Hunt, D., Zannino, D., et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: An analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 31 (2010), 92–99.
165. Kwong, R.Y., Sattar, H., Wu, H., et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118 (2008), 1011–1020.
166. Sgarbossa, E.B., Pinsky, S.L., Barbagelata, A., et al., GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block. N Engl J Med 334 (1996), 481–487.
167. Cai, Q., Mehta, N., Sgarbossa, E.B., et al. The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: From falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?. Am Heart J 166 (2013), 409–413.
168. Widimsky, P., Rohác, F., Stásek, J., et al. Primary angioplasty in acute myocardial infarction with right bundle branch block: Should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?. Eur Heart J 33 (2012), 86–95.
169. Brandt, R.R., Hammill, S.C., Higano, S.T., Electrocardiographic diagnosis of acute myocardial infarction during ventricular pacing. Circulation 97 (1998), 2274–2275.
170. Pradhan, R., Chaudhary, A., Donato, A.A., Predictive accuracy of ST depression during rapid atrial fibrillation on the presence of obstructive coronary artery disease. Am J Emerg Med 30 (2012), 1042–1047.
171. Androulakis, A., Aznaouridis, K.A., Aggeli, C.J., et al. Transient ST-segment depression during paroxysms of atrial fibrillation in otherwise normal individuals. J Am Coll Cardiol 50 (2007), 1909–1911.
172. Vakil, K., Gandhi, S., Abidi, K.S., et al. Deep T-wave inversions: Cardiac ischemia or memory?. J Cardiovasc Dis 2 (2014), 116–119.
173. Stillman, A.E., Oudkerk, M., Bluemke, D., et al. Assessment of acute myocardial infarction: Current status and recommendations from the North American Society for Cardiovascular Imaging and the European Society of Cardiac Radiology. Int J Cardiovasc Imaging 27 (2011), 7–24.
174. Scirica, B.M., Acute coronary syndrome: Emerging tools for diagnosis and risk assessment. J Am Coll Cardiol 55 (2010), 1403–1415.
175. Kontos, M.C., Diercks, D.B., Kirk, J.D., Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 85 (2010), 284–299.
176. Lewis, W.R., Echocardiography in the evaluation of patients in chest pain units. Cardiol Clin 23 (2005), 531–539.
177. Flachskampf, F.A., Schmid, M., Rost, C., Achenbach, S., de Maria, A.N., Daniel, W.G., Cardiac imaging after myocardial infarction. Eur Heart J 32 (2011), 272–283.
178. Zamorano, J., Wallbridge, D.R., Ge, J., Drozd, J., Nesser, J., Erbel, R., Non-invasive assessment of cardiac physiology by tissue Doppler echocardiography. Eur Heart J 18 (1997), 330–339.
179. Kaul, S., Miller, J.G., Grayburn, P.A., et al. A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr 24 (2011), 455–464.
180. O'Connor, M.K., Hammell, T., Gibbons, R.J., In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 17 (1990), 69–76.
181. Carrio, I., Cowie, M.R., Yamazaki, J., Udelson, J., Camici, P.G., Cardiac sympathetic imaging with mIBG in heart failure. J Am Coll Cardiol Img 3 (2010), 92–100.
182. Nahrendorf, M., Sosnovik, D.E., French, B.A., et al. Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging 2 (2009), 56–70.
183. Kramer, C.M., Sinusas, A.J., Sosnovik, D.E., French, B.A., Bengel, F.M., Multimodality imaging of myocardial injury and remodelling. J Nucl Med 51 (2010), 107S–121S.
184. Taegtmeyer, H., Tracing cardiac metabolism in vivo: One substrate at a time. J Nucl Med 51 (2010), 80S–87S.
185. Kim, H.W., Faraneh-Far, A., Kim, R.J., Cardiovascular magnetic resonance in patients with myocardial infarction. J Am Coll Cardiol 55 (2009), 1–16.
186. Beek, A.M., van Rossum, A.C., Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction. Heart 96 (2010), 237–243.
187. Locca, D., Bucciarelli-Ducci, C., Ferrante, G., et al. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?. J Am Coll Cardiol Intv 3 (2010), 950–958.
188. Schuleri, K.H., George, R.T., Lardo, A.C., Assessment of coronary blood flow with computed tomography and magnetic resonance imaging. J Nucl Cardiol 17 (2010), 582–590.
189. Dedic, A., Lubbers, M.M., Schaap, J., et al. Coronary CT angiography for suspected ACS in the era of high-sensitivity troponins: Randomized multicenter study. J Am Coll Cardiol 67 (2016), 16–26.
190. Eitel, I., de Waha, S., Wöhrle, J., et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64 (2014), 1217–1226.
191. Hoffmann, U., Truong, Q.A., Schoenfeld, D.A., et al., ROMICAT-II Investigators. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 367 (2012), 299–308.
192. Puchner, S.B., Liu, T., Mayrhofer, T., et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: Results from the ROMICAT-II trial. J Am Coll Cardiol 64 (2014), 684–692.
193. Ferencik, M., Liu, T., Mayrhofer, T., et al. hs-Troponin I followed by CT angiography improves acute coronary syndrome risk stratification accuracy and workup in acute chest pain patients: Results from ROMICAT II Trial. J Am Coll Cardiol Img 8 (2015), 1272–1281.
194. Amsterdam, E.A., Kirk, J.D., Bluemke, D.A., et al. Testing of low-risk patients presenting to the emergency department with chest pain: A scientific statement from the American Heart Association. Circulation 122 (2010), 1756–1776.
195. European Medicines Agency/Committee for Medicinal Products for Human Use (CHMP). Reflection paper on assessment of cardiovascular safety profile of medical products. EMA/CHMP/50549/2015. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/03/WC500203804.pdf. Accessed February 25, 2016.
196. Hicks, K.A., Mahaffey, K.W., Mehran, R., et al., Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). 2017 Cardiovascular and stroke endpoint definitions for clinical trials. J Am Coll Cardiol 71 (2018), 1021–1034.
197. Leening, M.J., Elias-Smale, S.E., Felix, J.F., et al. Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: The Rotterdam Study. Heart 96 (2010), 1458–1462.
198. Karnegis, J.N., Matts, J., Tuna, N., Development and evolution of electrocardiographic Minnesota Q-QS codes in patients with acute myocardial infarction. Am Heart J 110 (1985), 452–459.
199. Goyal, A., Gluckman, T.J., Tcheng, J.E., What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) codes and type 2 myocardial infarction. Circulation 136 (2017), 1180–1182.
200. Rosamond, W., Chambless, L., Heiss, G., et al. Twenty-two year trends in incidence of myocardial infarction, CHD mortality, and case-fatality in 4 US communities, 1987-2008. Circulation 125 (2012), 1848–1857.
201. Luepker, R., Duval, S., Jacobs, D., Smith, L., Berger, A., The effect of changing diagnostic algorithms on acute myocardial infarction rates. Ann Epidemiol 21 (2011), 824–829.